HLUN-A:CPH
H Lundbeck A/S Class A
45,05 DKK
arrow_upward
+0,33%(+0,15) 1D
16 ოქტ, 17:00:00 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUN-A...
Open
45,00 DKK
High
45,60 DKK
Low
44,90 DKK
Mkt. cap
47,05 მლრდ.
Avg. vol.
100,68 ათ.
Volume
0,00
52-wk high
45,60 DKK
52-wk low
31,40 DKK
Shares outstanding
199,15 მლნ.
No. of employees
5 ათ.
Open
45,00 DKK
High
45,60 DKK
Low
44,90 DKK
Mkt. cap
47,05 მლრდ.
Avg. vol.
100,68 ათ.
Volume
0,00
52-wk high
45,60 DKK
52-wk low
31,40 DKK
Shares outstanding
199,15 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
Yahoo! Finance Canada
·
25 წუთის წინ
NTHI,VITL,SRAD,HERZ,EFOR,TRIN,FFIN,NXRT,AVBC,CULP,BLCO,BBSI,VSNT,VIRC,GRNT,SSP,GAIA,CSPI,AFCG,AWRE,APCX,KLTR,AUBN,BETR | Stock Prices | Quote Comparison
AOL.com
·
25 წუთის წინ
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Simply Wall Street
·
1 საათის წინ
Is INmune Bio (NASDAQ:INMB) In A Good Position To Deliver On Growth Plans?
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOშარლ ვან ზილ
Employees5 ათ.
Founded1915
Headquarters-
SectorPharmaceutical industry
Websitelundbeck.com